APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174027290327 December 2025184 pages

Choose your research edition.

Industry ResearchPorcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine include Boehringer Ingelheim, Ceva, Merck, Pharmgate, Zoetis, SPAH, Huizhong Biological, Jiangsu Nannong Hi-Tech and Jinyu Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Company

Boehringer Ingelheim

Ceva

Merck

Pharmgate

Zoetis

SPAH

Huizhong Biological

Jiangsu Nannong Hi-Tech

Jinyu Biotechnology

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Type

One-dose Type

Two-dose Type

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Application

Piglet

Adult Pig

Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Trends Table 2. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Drivers Table 3. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Opportunities and Challenges Table 4. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Restraints Table 5. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Manufacturers Table 9. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturers, Product Type & Application Table 13. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of One-dose Type Table 17. Major Manufacturers of Two-dose Type Table 18. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Piglet Table 29. Major Manufacturers of Adult Pig Table 30. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2027-2032) Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. Ceva Company Information Table 68. Ceva Business Overview Table 69. Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 71. Ceva Recent Development Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 76. Merck Recent Development Table 77. Pharmgate Company Information Table 78. Pharmgate Business Overview Table 79. Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 81. Pharmgate Recent Development Table 82. Zoetis Company Information Table 83. Zoetis Business Overview Table 84. Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 86. Zoetis Recent Development Table 87. SPAH Company Information Table 88. SPAH Business Overview Table 89. SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 91. SPAH Recent Development Table 92. Huizhong Biological Company Information Table 93. Huizhong Biological Business Overview Table 94. Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 96. Huizhong Biological Recent Development Table 97. Jiangsu Nannong Hi-Tech Company Information Table 98. Jiangsu Nannong Hi-Tech Business Overview Table 99. Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 101. Jiangsu Nannong Hi-Tech Recent Development Table 102. Jinyu Biotechnology Company Information Table 103. Jinyu Biotechnology Business Overview Table 104. Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio Table 106. Jinyu Biotechnology Recent Development Table 107. Key Raw Materials Table 108. Raw Materials Key Suppliers Table 109. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Distributors List Table 110. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Customers List Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Image Figure 2. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. One-dose Type Image Figure 9. Two-dose Type Image Figure 10. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Piglet Image Figure 17. Adult Pig Image Figure 18. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • One-dose Type
  • Two-dose Type
Applications
  • Piglet
  • Adult Pig
Companies covered
  • Boehringer Ingelheim
  • Ceva
  • Merck
  • Pharmgate
  • Zoetis
  • SPAH
  • Huizhong Biological
  • Jiangsu Nannong Hi-Tech
  • Jinyu Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market Dynamics
  1. 2.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Trends
  2. 2.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Drivers
  3. 2.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Opportunities and Challenges
  4. 2.4 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Restraints
3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Manufacturers
  1. 3.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Tier 1, Tier 2, and Tier 3
4 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Type
  1. 4.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Type Introduction
  2. 4.1.1 One-dose Type
  3. 4.1.2 Two-dose Type
  4. 4.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type
  5. 4.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type
  9. 4.3.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Type (2021-2032)
5 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Market by Application
  1. 5.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Application Introduction
  2. 5.1.1 Piglet
  3. 5.1.2 Adult Pig
  4. 5.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application
  5. 5.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application
  9. 5.3.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Application (2021-2032)
6 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region
  1. 6.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region
  1. 7.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region
  2. 7.1.1 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boehringer Ingelheim
  2. 8.1.1 Boehringer Ingelheim Company Information
  3. 8.1.2 Boehringer Ingelheim Business Overview
  4. 8.1.3 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boehringer Ingelheim Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  6. 8.1.5 Boehringer Ingelheim Recent Developments
  7. 8.2 Ceva
  8. 8.2.1 Ceva Company Information
  9. 8.2.2 Ceva Business Overview
  10. 8.2.3 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ceva Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  12. 8.2.5 Ceva Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pharmgate
  20. 8.4.1 Pharmgate Company Information
  21. 8.4.2 Pharmgate Business Overview
  22. 8.4.3 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pharmgate Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  24. 8.4.5 Pharmgate Recent Developments
  25. 8.5 Zoetis
  26. 8.5.1 Zoetis Company Information
  27. 8.5.2 Zoetis Business Overview
  28. 8.5.3 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zoetis Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  30. 8.5.5 Zoetis Recent Developments
  31. 8.6 SPAH
  32. 8.6.1 SPAH Company Information
  33. 8.6.2 SPAH Business Overview
  34. 8.6.3 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SPAH Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  36. 8.6.5 SPAH Recent Developments
  37. 8.7 Huizhong Biological
  38. 8.7.1 Huizhong Biological Company Information
  39. 8.7.2 Huizhong Biological Business Overview
  40. 8.7.3 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huizhong Biological Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  42. 8.7.5 Huizhong Biological Recent Developments
  43. 8.8 Jiangsu Nannong Hi-Tech
  44. 8.8.1 Jiangsu Nannong Hi-Tech Company Information
  45. 8.8.2 Jiangsu Nannong Hi-Tech Business Overview
  46. 8.8.3 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Nannong Hi-Tech Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  48. 8.8.5 Jiangsu Nannong Hi-Tech Recent Developments
  49. 8.9 Jinyu Biotechnology
  50. 8.9.1 Jinyu Biotechnology Company Information
  51. 8.9.2 Jinyu Biotechnology Business Overview
  52. 8.9.3 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jinyu Biotechnology Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Product Portfolio
  54. 8.9.5 Jinyu Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Value Chain Analysis
  2. 9.1.1 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Production Mode & Process
  6. 9.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Distributors
  9. 9.2.3 Porcine Circovirus-Mycoplasma Hyopneumoniae Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst